Bulletin
Investor Alert

New York Markets Open in:

Market Pulse Archives

Feb. 24, 2020, 10:23 a.m. EST

Sanofi says it's considering IPO of pharmaceutical-ingredients arm

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Sanofi ADR (SNY)
  • X
    Sanofi S.A. (SAN)
  • X
    Euronext N.V. (ENX)

or Cancel Already have a watchlist? Log In

By Steve Goldstein

French drugmaker Sanofi /zigman2/quotes/201967021/composite SNY -0.86% /zigman2/quotes/206928357/delayed FR:SAN -3.30% announced plans to split off its unit producing and marketing active pharmaceutical ingredients for a possible IPO in 2022. Sanofi plans to create the company from six of its production sites, in France, Germany, Italy, the U.K. and Hungary. Sanofi said the new company would rank as the world's second largest API company with approximately €1 billion in expected sales by 2022. A planned IPO on Euronext Paris /zigman2/quotes/208368645/delayed FR:ENX -0.39% would be evaluated with a decision expected by 2022, subject to market conditions. Sanofi said it would become a customer, hold a minority stake of 30% and spin off the company without debt. Sanofi's shares were lower for the day due to the spreading coronavirus, but the IPO plans helped the stock to limit losses.

/zigman2/quotes/201967021/composite
US : U.S.: Nasdaq
$ 48.66
-0.42 -0.86%
Volume: 2.73M
Aug. 9, 2022 4:00p
P/E Ratio
16.37
Dividend Yield
2.59%
Market Cap
$124.61 billion
Rev. per Employee
$474,871
loading...
/zigman2/quotes/206928357/delayed
FR : France: Euronext Paris
92.33
-3.15 -3.30%
Volume: 797,363
Aug. 10, 2022 1:32p
P/E Ratio
17.51
Dividend Yield
3.61%
Market Cap
€121.96 billion
Rev. per Employee
€421,366
loading...
/zigman2/quotes/208368645/delayed
FR : France: Euronext Paris
82.28
-0.32 -0.39%
Volume: 12,748
Aug. 10, 2022 1:31p
P/E Ratio
16.87
Dividend Yield
2.35%
Market Cap
€8.79 billion
Rev. per Employee
€721,030
loading...

Get news alerts on Sanofi ADR — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.